- Filed
- Apr 26, 2019 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2017 · Apr 18, 2019 | 39.85M sh |
| Shares Diluted | Q1 2017 · Mar 31, 2017 | 38.44M sh |
| Shares Diluted | Q1 2017 · Mar 31, 2016 | 36.53M sh |
| Capex | Q1 2017 · Mar 31, 2017 | $5.58M |
| Capex | Q1 2017 · Mar 31, 2016 | $3.33M |
| Long Term Debt | Q1 2017 · Mar 31, 2017 | $246.4M |
| Long Term Debt | Q1 2017 · Dec 31, 2016 | $248.85M |
| Cash And Equivalents restated | Q1 2017 · Mar 31, 2017 | $610.43M |
| Cash And Equivalents restated | Q1 2017 · Dec 31, 2016 | $672.61M |
| Cash And Equivalents | Q1 2017 · Mar 31, 2016 | $562.44M |
| Cash And Equivalents | Q1 2017 · Dec 31, 2015 | $500.92M |
| Stockholders Equity restated | Q1 2017 · Mar 31, 2017 | $421.43M |
| Stockholders Equity restated | Q1 2017 · Dec 31, 2016 | $397.64M |
| Current Liabilities restated | Q1 2017 · Mar 31, 2017 | $647.58M |
| Current Liabilities restated | Q1 2017 · Dec 31, 2016 | $681.79M |
| Total Liabilities restated | Q1 2017 · Mar 31, 2017 | $903.43M |
| Total Liabilities restated | Q1 2017 · Dec 31, 2016 | $938.14M |
| Current Assets restated | Q1 2017 · Mar 31, 2017 | $781.15M |
| Current Assets restated | Q1 2017 · Dec 31, 2016 | $786.61M |
| Total Assets restated | Q1 2017 · Mar 31, 2017 | $1.32B |
| Total Assets restated | Q1 2017 · Dec 31, 2016 | $1.34B |
| Eps Diluted restated | Q1 2017 · Mar 31, 2017 | $0.42 |
| Eps Diluted | Q1 2017 · Mar 31, 2016 | $0.16 |
| Eps Basic restated | Q1 2017 · Mar 31, 2017 | $0.43 |
| Eps Basic | Q1 2017 · Mar 31, 2016 | $0.16 |
| Net Income restated | Q1 2017 · Mar 31, 2017 | $16.06M |
| Net Income | Q1 2017 · Mar 31, 2016 | $5.8M |
| Operating Income restated | Q1 2017 · Mar 31, 2017 | $23.13M |
| Operating Income | Q1 2017 · Mar 31, 2016 | $9.93M |
| Stock Repurchased | Q1 2017 · Mar 31, 2016 | $9.4M |